Innovation Endeavors and the LEO Science & Tech Hub kick off a Deep Life Challenge program. Allergan Aesthetics, an AbbVie company, and Skinbetter Science launch a new long-term, educational initiative: The DREAM (Driving Racial Equity in Aesthetic Medicine) Initiative. The San Diego Dermatology Symposium inaugural meeting adopts a virtual format to deliver updates on topics ranging from acne, rosacea and psoriasis to skin cancer diagnosis and social media.
SBA Loans and Paycheck Protection Program (PPP) loans for practices impacted by the coronavirus pandemic are among the options addressed in a new video series, “Coping with COVID-19.” Eli Lilly and Company's Taltz is now approved to manage moderate to severe plaque psoriasis in pediatric patients ages 6 to under 18. LEO Pharma’s Finacea Foam (azelaic acid 15%) is back in pharmacies—just in time for Rosacea Awareness Month.
2018 saw new approvals and clearances for acne, impetigo, psoriasis, and skin cancer from Ortho Dermatologics, Sun Pharma, Cutanea, and more. Plus, updates for Restylane, new devices from BTL, Cutera, and others.
DermWireTV: LEO Science & Tech Hub, Allergan/SkinBetter DREAM Initiative, San Diego Dermatology Symposium
DermWireTV: AcneAlly Launches, Rosacea Insights, MC2/EPI Collaboration
New Dermatology Atlas to Highlight and Compare Features of Common Dermatologic Conditions in Different Skin Types
Resident of Distinction Award Celebrates 10th Anniversary at 2020 Caribbean Dermatology Symposium